SEC Ruling Forces D.E. Shaw Portfolio Disclosure
NEW YORK (HedgeWorld.com)--After years of shielding the details of its massive stock portfolio from the prying eyes of the public, and potentially competitors, hedge fund firm D.E. Shaw & Co. Inc. has been forced by the Securities and Exchange Commission to disclose every last share of its US$21.3 billion in...
Evan McCulloch of Franklin Biotechnology Discovery Fund
S&P Rank: 3 Stars March 11, 2004 Biotechs High on Drug Approvals